Bumper Offer - Urjas oil Just @ Rs. 1
Levera 500 Tablet (15) is a prescription drug, available for use as Tablet. It is typically used for the treatment of Epilepsy. Other than this, Levera 500 Tablet (15) has some other therapeutic uses, which have been discussed ahead.
The right dosage of Levera 500 Tablet (15) depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The side effects typically associated with Levera 500 Tablet (15) include Fatigue, Headache, Drowsiness. Besides the aforementioned side effects, there are other adverse effects of Levera 500 Tablet (15) as well, which are listed below. Usually, these side effects of Levera 500 Tablet (15) go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Levera 500 Tablet (15)'s effect during pregnancy is Moderate and Mild while nursing. It is important to know if Levera 500 Tablet (15) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Levera 500 Tablet (15) related warnings section.
Other contraindications of Levera 500 Tablet (15) have been discussed in the sections ahead.
Besides this, Levera 500 Tablet (15) may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Levera 500 Tablet (15), it is important to know that it is not safe while driving, and is not habit-forming.
Levera 500 Tablet (15) is used to treat the following -
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Levera 500 Tablet (15) safe for pregnant women?
Levera can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Levera right away. Take your doctor's advice before taking it again.
Is the use of Levera 500 Tablet (15) safe during breastfeeding?
Breastfeeding women can take Levera as it bears very minor side effects for them.
What is the effect of Levera 500 Tablet (15) on the Kidneys?
Levera rarely harms the kidneys.
What is the effect of Levera 500 Tablet (15) on the Liver?
Side effects of Levera rarely affect the liver.
What is the effect of Levera 500 Tablet (15) on the Heart?
There are no any side effects of Levera for the heart.
Levera 500 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Levera 500 Tablet (15) unless your doctor advises you to do so -
Is this Levera 500 Tablet (15) habit forming or addictive?
No, there is no any evidence that Levera 500 Tablet (15) is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Levera 500 Tablet (15) as you may feel sleepy.
Is it safe?
Yes, Levera 500 Tablet (15) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, this Levera 500 Tablet (15) works for mental disorders.
Interaction between Food and Levera 500 Tablet (15)
Taking Levera 500 Tablet (15) with food does not harm your health.
Interaction between Alcohol and Levera 500 Tablet (15)
Consumption of alcohol and Levera 500 Tablet (15) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
